$ZENA ZenaTech unveils its strategy for Zoo Office™, a

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
53
$ZENA ZenaTech unveils its strategy for Zoo Office™, a unified AI-powered productivity platform that will serve as a future unifying foundation and brand for ZenaTech's Enterprise SaaS ecosystem and capitalize on the rapidly growing Agentic AI market. Designed to bring advanced productivity, operational tools, agentic AI capabilities, and industry-specific applications together within a single business platform, Zoo Office represents ZenaTech's vision for a more connected and intelligent software experience.

"We want to future-proof and enhance our enterprise SaaS solutions beyond traditional software tools, adding intelligent productivity that can automate workflows, execute tasks, and enhance decision-making. Our goal is to deliver greater customer value and recurring revenue opportunities while leveraging agentic AI, one of the fastest-growing segments of the enterprise software market," said

@ShaunPassleyPhD

, ZenaTech CEO. "We believe the future of software is not more applications, but fewer, smarter, and more personalized platforms. Zoo Office is our vision for an AI-native business environment where applications, workflows, data, and organizational knowledge work together through a shared business context layer. As businesses increasingly adopt AI-driven solutions to improve efficiency and reduce costs, we see an opportunity to accelerate our enterprise SaaS segment growth and contribute to creating long-term shareholder value."

Read the full story: https://zenatech.com/zenatech-unveils-zoo-off...ai-market/

$ZENA

$49Q #ZenaTech #ZooOffice #AgenticAI #EnterpriseSaaS #ArtificialIntelligence #BusinessAutomation #FutureOfWork #DigitalTransformation https://x.com/ZenatechInc/status/2067642046777848062  

ZenaTech Inc. (ZENA) Stock Research Links

ZENA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Huawei Introduces Innovative Wearables for Enhanced Connectivity

Updated Category News Views 293

Huawei Unveils Next-Generation Wearables and Tablets At a much-anticipated event, Huawei Consumer Business Group (CBG) revealed a thrilling array of new products. This launch showcased a strong emphasis on trendy wearables and sophisticated tablets, highlighting the brand's dedication to innovation and a user-friendly design. Chic Wearables for Style and Utility Among the...

Continue Reading
Investigating Barnes & Noble Education: Shareholder Rights Explained

Updated Category News Views 155

Understanding the Investigation of Barnes & Noble Education In a proactive move for investors, the law firm Bragar Eagel & Squire, P.C. is currently investigating Barnes & Noble Education, Inc. (BNED). This investigation aims to determine whether the company potentially breached federal securities laws or engaged in unlawful business practices that could lead to...

Continue Reading
Bailey Kennedy Achieves Landmark Legal Win for Talisman Group

Updated Category News Views 171

Bailey Kennedy Achieves Legal Victory for Talisman Group Judge Rules LNW Violated Talisman's Distribution Agreement by Marketing Competing Game In a significant legal development, Bailey Kennedy, LLP has successfully represented The Talisman Group, LLC, the innovative minds behind EZ Baccarat. The firm has recently triumphed in a legal dispute against LNW Gaming, Inc.,...

Continue Reading
Join the Class Action Lawsuit Against Ardelyx, Inc. Now

Updated Category News Views 49

Join the Class Action Lawsuit Against Ardelyx, Inc. Attention Ardelyx, Inc. investors! There's an important class action lawsuit underway, and this is your opportunity to get involved. Bronstein, Gewirtz & Grossman, LLC, a respected law firm known for its dedication to investor advocacy, has announced a class action case involving Ardelyx, Inc. (NASDAQ: ARDX) and certain...

Continue Reading
Aileron Therapeutics Unveils Q3 2024 Financial Performance

Updated Category News Views 97

Aileron Therapeutics Reports Impressive Q3 2024 Financial Results Aileron Therapeutics, Inc. (NASDAQ: ALRN), a biopharmaceutical company committed to developing innovative medicines for orphan pulmonary diseases, has recently showcased significant progress with their third-quarter financial results. This quarter has been marked by promising advancements in clinical trials...

Continue Reading